Isoproterenol

CHEMBL434 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
211.3 g/mol
LogP
-0.6
Phase
4

This synthetic catecholamine acts as a non-selective beta-adrenergic agonist, stimulating both beta-1 receptors in the heart (increasing heart rate and contractility) and beta-2 receptors in the lungs (causing bronchodilation). It is used in emergency settings for heart block, bradycardia, and bronchospasm. Its cardiac-stimulating effects limit its use compared to more selective agents.

Moleküler Ağırlık

211,2600 g/mol

LogP

-0,60

TPSA

72,70 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NCC(O)c1ccc(O)c(O)c1

InChI

InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3

Molecular Formula

C11H17NO3

HBD / HBA

4 / 4

Döndürülebilir Bağlar

4

Ağır Atomlar

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This synthetic catecholamine acts as a non-selective beta-adrenergic agonist, stimulating both beta-1 receptors in the heart (increasing heart rate and contractility) and beta-2 receptors in the lungs (causing bronchodilation). It is used in emergency settings for heart block, bradycardia, and bronchospasm. Its cardiac-stimulating effects limit its use compared to more selective agents.

Yes, Isoproterenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL434. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3779. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.